Search by Drug Name or NDC
NDC 00143-9871-01 Cladribine 1 mg/mL Details
Cladribine 1 mg/mL
Cladribine is a INTRAVENOUS INJECTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Hikma Pharmaceuticals USA Inc.. The primary component is CLADRIBINE.
MedlinePlus Drug Summary
Cladribine is used to treat hairy cell leukemia (cancer of a certain type of white blood cell). Cladribine is in a class of medications known as purine analogs. It works by stopping or slowing the growth of cancer cells.
Related Packages: 00143-9871-01Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Cladribine Injection
Product Information
| NDC | 00143-9871 |
|---|---|
| Product ID | 0143-9871_5aef0cdc-fa27-47a1-8cce-2a3201aba276 |
| Associated GPIs | 21300007002015 |
| GCN Sequence Number | 019181 |
| GCN Sequence Number Description | cladribine VIAL 10 MG/10ML INTRAVEN |
| HIC3 | V1B |
| HIC3 Description | ANTINEOPLASTIC - ANTIMETABOLITES |
| GCN | 00880 |
| HICL Sequence Number | 007840 |
| HICL Sequence Number Description | CLADRIBINE |
| Brand/Generic | Generic |
| Proprietary Name | Cladribine |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Cladribine |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 1 |
| Active Ingredient Units | mg/mL |
| Substance Name | CLADRIBINE |
| Labeler Name | Hikma Pharmaceuticals USA Inc. |
| Pharmaceutical Class | Purine Antimetabolite [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA075405 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00143-9871-01 (00143987101)
| NDC Package Code | 0143-9871-01 |
|---|---|
| Billing NDC | 00143987101 |
| Package | 1 VIAL in 1 BOX, UNIT-DOSE (0143-9871-01) / 10 mL in 1 VIAL |
| Marketing Start Date | 2000-02-28 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |